BBSRC invests £48m in Babraham Institute to advance lifelong health research by Jen Brogan | May 13, 2024 | News | 0 The funding will help to support research across epigenetics, immunology and cell signalling Read More
Biomodal releases genetics and epigenetics solution by John Pinching | Apr 14, 2023 | News | 0 Product delivers epigenetic information from a single low-input DNA library without medical treatment Read More
CRT picks up ‘success payment’ from GSK by Selina McKee | Oct 7, 2016 | News | 0 GlaxoSmithKline has issued an undisclosed ‘success payment’ to Cancer Research Technology relating to a collaboration developing molecules targeting cancer epigenetics – the way cells control how and when genes are turned on or off. Read More